✦ LIBER ✦

Activity and Safety of Pegylated Liposomal Doxorubicin as First-Line Therapy in the Treatment of Non-Visceral Classic Kaposi's Sarcoma: A Multicenter Study

✍ Scribed by Di Lorenzo, Giuseppe; Kreuter, Alexander; Di Trolio, Rossella; Guarini, Attilio; Romano, Carmela; Montesarchio, Vincenzo; Brockmeyer, Norbert H; De Placido, Sabino; Bower, Mark; Dezube, Bruce J

Book ID: 110050180
Publisher: Nature Publishing Group
Year: 2008
Tongue: English
Weight: 69 KB
Volume: 128
Category: Article
ISSN: 0022-202X
DOI: 10.1038/sj.jid.5701215

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pegylated liposomal doxorubicin as secon

Pegylated liposomal doxorubicin as second-line therapy in the treatment of patients with advanced classic Kaposi sarcoma : A retrospective study

✍ Giuseppe Di Lorenzo; Rossella Di Trolio; Vincenzo Montesarchio; Giovanna Palmier 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 1 views

## Abstract ## BACKGROUND. Classic Kaposi sarcoma (CKS) is a rare neoplasm that predominantly occurs in elderly subjects and has a variable clinical evolution. The clinical course is usually indolent, but occasionally the neoplasm progresses rapidly and spreads to internal organs, necessitating sy